Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc (CYTK) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1061983.
Total stock buying since 2015: $3,409,639.
Total stock sales since 2015: $141,802,280.
Total stock option exercises since 2015: $22,061,108.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 301,628 | $12,455,598 | 87,000 | $1,012,460 |
| 2024 | 0 | $0 | 566,913 | $33,770,931 | 441,385 | $3,574,553 |
| 2023 | 0 | $0 | 336,003 | $12,584,418 | 302,540 | $2,503,702 |
| 2022 | 0 | $0 | 602,547 | $26,510,660 | 622,168 | $5,834,212 |
| 2021 | 0 | $0 | 481,309 | $16,423,971 | 491,287 | $4,201,854 |
| 2020 | 0 | $0 | 1,947,945 | $35,408,116 | 442,810 | $3,361,709 |
| 2019 | 348,072 | $3,280,519 | 64,000 | $656,817 | 0 | $0 |
| 2018 | 0 | $0 | 50,709 | $406,852 | 2,709 | $17,798 |
| 2017 | 0 | $0 | 229,802 | $3,344,442 | 182,703 | $1,417,008 |
| 2016 | 0 | $0 | 5,633 | $69,632 | 0 | $0 |
| 2015 | 21,000 | $129,120 | 21,875 | $170,843 | 21,875 | $137,812 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-12 | Henderson John T (Director) | Option Ex | 5,000 | 4.44 | 22,200 |
| 2024-01-04 | Malik Fady Ibraham (EVP Research & Development) | Sale | 15,678 | 86.98 | 1,363,750 |
| 2024-01-04 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 11,678 | 7.96 | 92,956 |
| 2024-01-02 | Blum Robert I (President & CEO) | Sale | 12,500 | 85.08 | 1,063,500 |
| 2024-01-02 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-12-27 | Wierenga Wendall (Director) | Sale | 10,000 | 73.60 | 736,000 |
| 2023-12-27 | Wierenga Wendall (Director) | Option Ex | 10,000 | 4.44 | 44,400 |
| 2023-12-18 | Blum Robert I (President & CEO) | Sale | 12,500 | 36.95 | 461,875 |
| 2023-12-18 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-12-18 | Henderson John T (Director) | Sale | 2,458 | 36.34 | 89,323 |
| 2023-12-18 | Henderson John T (Director) | Option Ex | 13,020 | 6.72 | 87,494 |
| 2023-11-30 | Blum Robert I (President & CEO) | Sale | 12,500 | 32.99 | 412,375 |
| 2023-11-30 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-11-15 | Blum Robert I (President & CEO) | Sale | 12,500 | 34.57 | 432,125 |
| 2023-11-15 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-11-09 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,500 | 35.40 | 88,500 |
| 2023-10-30 | Blum Robert I (President & CEO) | Sale | 12,500 | 32.17 | 402,125 |
| 2023-10-30 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-10-16 | Blum Robert I (President & CEO) | Sale | 12,500 | 33.70 | 421,250 |
| 2023-10-16 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-10-12 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,500 | 35.89 | 89,725 |
| 2023-10-06 | Blum Robert I (President & CEO) | Sale | 12,500 | 30.00 | 375,000 |
| 2023-10-06 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-09-14 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,500 | 34.86 | 87,150 |
| 2023-09-13 | Blum Robert I (President & CEO) | Sale | 12,500 | 34.90 | 436,212 |
| 2023-09-13 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2023-08-25 | Blum Robert I (President & CEO) | Sale | 12,500 | 33.99 | 424,875 |
| 2023-08-25 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 7.32 | 91,437 |
| 2023-08-21 | Wierenga Wendall (Director) | Sale | 6,020 | 32.02 | 192,760 |
| 2023-08-21 | Wierenga Wendall (Director) | Option Ex | 6,020 | 6.72 | 40,454 |
| 2023-08-11 | Blum Robert I (President & CEO) | Sale | 12,500 | 32.37 | 404,587 |
| 2023-08-11 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 8.80 | 110,062 |
| 2023-08-10 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,500 | 31.70 | 79,250 |
| 2023-08-01 | Blum Robert I (President & CEO) | Sale | 12,500 | 32.63 | 407,862 |
| 2023-08-01 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-07-13 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,500 | 35.37 | 88,425 |
| 2023-07-13 | Blum Robert I (President & CEO) | Sale | 12,500 | 35.27 | 440,937 |
| 2023-07-13 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-07-07 | Bhanji Muna (Director) | Sale | 2,000 | 34.12 | 68,234 |
| 2023-07-03 | Blum Robert I (President & CEO) | Sale | 12,500 | 32.60 | 407,500 |
| 2023-07-03 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-06-12 | Blum Robert I (President & CEO) | Sale | 12,500 | 37.06 | 463,250 |
| 2023-06-12 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-06-08 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,500 | 38.07 | 95,175 |
| 2023-05-31 | Blum Robert I (President & CEO) | Sale | 12,500 | 37.67 | 470,875 |
| 2023-05-31 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-05-16 | Blum Robert I (President & CEO) | Sale | 12,500 | 37.41 | 467,624 |
| 2023-05-16 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-05-11 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,787 | 39.50 | 70,586 |
| 2023-05-03 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,000 | 40.00 | 280,000 |
| 2023-05-03 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 7,000 | 7.96 | 55,720 |
| 2023-04-28 | Blum Robert I (President & CEO) | Sale | 12,500 | 37.68 | 471,000 |
| 2023-04-28 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-04-14 | Blum Robert I (President & CEO) | Sale | 12,500 | 35.61 | 445,125 |
| 2023-04-14 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-04-13 | Malik Fady Ibraham (EVP Research & Development) | Sale | 4,000 | 34.21 | 136,840 |
| 2023-03-28 | Blum Robert I (President & CEO) | Sale | 12,500 | 35.05 | 438,124 |
| 2023-03-28 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-03-09 | Malik Fady Ibraham (EVP Research & Development) | Sale | 4,000 | 39.10 | 156,400 |
| 2023-03-06 | Blum Robert I (President & CEO) | Sale | 12,500 | 39.94 | 499,250 |
| 2023-03-06 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 9.65 | 120,625 |
| 2023-02-21 | Wong Robert (VP, Chief Accounting Officer) | Sale | 2,234 | 45.21 | 100,999 |
| 2023-02-09 | Malik Fady Ibraham (EVP Research & Development) | Sale | 11,000 | 43.73 | 481,100 |
| 2023-02-09 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 7,000 | 7.96 | 55,720 |
| 2023-02-06 | Wierenga Wendall (Director) | Sale | 7,000 | 45.00 | 315,000 |
| 2023-02-06 | Wierenga Wendall (Director) | Option Ex | 7,000 | 6.72 | 47,040 |
| 2023-02-03 | Wong Robert (VP, Chief Accounting Officer) | Sale | 3,004 | 45.00 | 135,180 |
| 2023-02-03 | Jaw Ching (SVP Finance & CFO) | Sale | 15,000 | 45.00 | 675,000 |
| 2023-02-03 | Jaw Ching (SVP Finance & CFO) | Option Ex | 15,000 | 12.10 | 181,500 |
| 2023-01-12 | Malik Fady Ibraham (EVP Research & Development) | Sale | 4,000 | 40.47 | 161,880 |
| 2022-12-21 | Blum Robert I (President & CEO) | Sale | 10,000 | 43.92 | 439,240 |
| 2022-12-21 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 9.65 | 96,500 |
| 2022-12-08 | Malik Fady Ibraham (EVP Research & Development) | Sale | 4,000 | 36.28 | 145,120 |
| 2022-12-05 | Blum Robert I (President & CEO) | Sale | 10,000 | 39.30 | 392,969 |
| 2022-12-05 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 9.65 | 96,500 |
| 2022-11-21 | Blum Robert I (President & CEO) | Sale | 20,000 | 40.89 | 817,800 |
| 2022-11-21 | Blum Robert I (President & CEO) | Option Ex | 20,000 | 9.65 | 193,000 |
| 2022-11-10 | Malik Fady Ibraham (EVP Research & Development) | Sale | 8,000 | 38.04 | 304,320 |
| 2022-11-02 | Blum Robert I (President & CEO) | Sale | 10,000 | 42.17 | 421,700 |
| 2022-11-02 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 8.80 | 88,050 |
| 2022-10-19 | Blum Robert I (President & CEO) | Sale | 10,000 | 47.86 | 478,600 |
| 2022-10-19 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-10-13 | Malik Fady Ibraham (EVP Research & Development) | Sale | 21,513 | 47.28 | 1,017,134 |
| 2022-10-13 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 21,513 | 9.65 | 207,600 |
| 2022-10-03 | Blum Robert I (President & CEO) | Sale | 10,000 | 50.40 | 504,000 |
| 2022-10-03 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-09-19 | Blum Robert I (President & CEO) | Sale | 10,000 | 51.42 | 514,200 |
| 2022-09-19 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-09-07 | Blum Robert I (President & CEO) | Sale | 10,000 | 49.11 | 491,100 |
| 2022-09-07 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-09-02 | Smith Sandford D (Director) | Sale | 11,369 | 53.97 | 613,584 |
| 2022-09-02 | Smith Sandford D (Director) | Option Ex | 11,369 | 24.30 | 276,232 |
| 2022-09-01 | Wierenga Wendall (Director) | Sale | 4,166 | 52.79 | 219,923 |
| 2022-09-01 | Wierenga Wendall (Director) | Option Ex | 4,166 | 6.78 | 28,245 |
| 2022-09-01 | Parshall B Lynne (Director) | Sale | 60,592 | 52.79 | 3,198,650 |
| 2022-09-01 | Parshall B Lynne (Director) | Option Ex | 60,592 | 8.34 | 505,336 |
| 2022-09-01 | Costa Santo J (Director) | Sale | 30,000 | 52.79 | 1,583,700 |
| 2022-09-01 | Costa Santo J (Director) | Option Ex | 30,000 | 10.06 | 301,950 |
| 2022-08-05 | Kaye Edward M. Md (Director) | Sale | 11,428 | 50.00 | 571,400 |
| 2022-08-05 | Kaye Edward M. Md (Director) | Option Ex | 11,428 | 8.75 | 99,995 |
| 2022-08-01 | Blum Robert I (President & CEO) | Sale | 10,000 | 41.26 | 412,600 |
| 2022-08-01 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-07-18 | Blum Robert I (President & CEO) | Sale | 10,000 | 40.49 | 404,900 |
| 2022-07-18 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-07-14 | Malik Fady Ibraham (EVP Research & Development) | Sale | 21,500 | 43.43 | 933,745 |
| 2022-07-14 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 21,500 | 9.65 | 207,475 |
| 2022-07-06 | Blum Robert I (President & CEO) | Sale | 10,000 | 44.38 | 443,800 |
| 2022-07-06 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-06-15 | Blum Robert I (President & CEO) | Sale | 10,000 | 39.40 | 394,000 |
| 2022-06-15 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-06-09 | Malik Fady Ibraham (EVP Research & Development) | Sale | 21,500 | 40.62 | 873,330 |
| 2022-06-09 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 21,500 | 9.65 | 207,475 |
| 2022-06-06 | Blum Robert I (President & CEO) | Sale | 10,000 | 41.23 | 412,299 |
| 2022-06-06 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-05-16 | Blum Robert I (President & CEO) | Sale | 10,000 | 43.11 | 431,070 |
| 2022-05-16 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-05-12 | Malik Fady Ibraham (EVP Research & Development) | Sale | 13,987 | 37.54 | 525,071 |
| 2022-05-12 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 13,987 | 9.65 | 134,974 |
| 2022-04-20 | Blum Robert I (President & CEO) | Sale | 10,000 | 37.89 | 378,870 |
| 2022-04-20 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-04-07 | Malik Fady Ibraham (EVP Research & Development) | Sale | 23,148 | 42.59 | 985,757 |
| 2022-04-07 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 23,148 | 6.00 | 138,888 |
| 2022-04-05 | Jaw Ching (SVP Finance & CFO) | Sale | 10,000 | 42.00 | 420,000 |
| 2022-04-05 | Jaw Ching (SVP Finance & CFO) | Option Ex | 10,000 | 12.10 | 121,000 |
| 2022-04-04 | Jaw Ching (SVP Finance & CFO) | Sale | 15,000 | 40.00 | 600,000 |
| 2022-04-04 | Jaw Ching (SVP Finance & CFO) | Option Ex | 15,000 | 12.10 | 181,500 |
| 2022-04-04 | Blum Robert I (President & CEO) | Sale | 10,000 | 38.78 | 387,830 |
| 2022-04-04 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-03-21 | Blum Robert I (President & CEO) | Sale | 10,000 | 36.03 | 360,340 |
| 2022-03-21 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-03-15 | Schlossberg Mark A (SVP - Legal & General Counsel) | Sale | 25,196 | 33.96 | 855,731 |
| 2022-03-15 | Schlossberg Mark A (SVP - Legal & General Counsel) | Option Ex | 60,817 | 11.94 | 726,337 |
| 2022-03-10 | Malik Fady Ibraham (EVP Research & Development) | Sale | 26,852 | 37.82 | 1,015,462 |
| 2022-03-10 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 26,852 | 6.00 | 161,112 |
| 2022-03-09 | Jaw Ching (SVP Finance & CFO) | Sale | 15,000 | 38.00 | 570,000 |
| 2022-03-09 | Jaw Ching (SVP Finance & CFO) | Option Ex | 15,000 | 12.10 | 181,500 |
| 2022-03-02 | Blum Robert I (President & CEO) | Sale | 10,000 | 36.31 | 363,140 |
| 2022-03-02 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-03-02 | Costa Santo J (Director) | Sale | 10,000 | 37.35 | 373,480 |
| 2022-03-02 | Costa Santo J (Director) | Option Ex | 10,000 | 10.68 | 106,800 |
| 2022-02-16 | Blum Robert I (President & CEO) | Sale | 10,000 | 36.50 | 364,970 |
| 2022-02-16 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2022-02-07 | Blum Robert I (President & CEO) | Sale | 10,000 | 33.86 | 338,590 |
| 2022-02-07 | Blum Robert I (President & CEO) | Option Ex | 10,000 | 7.96 | 79,600 |
| 2021-12-27 | Smith Sandford D (Director) | Sale | 28,290 | 45.79 | 1,295,399 |
| 2021-12-27 | Smith Sandford D (Director) | Option Ex | 28,290 | 20.45 | 578,615 |
| 2021-12-27 | Wierenga Wendall (Director) | Sale | 4,166 | 44.37 | 184,853 |
| 2021-12-27 | Wierenga Wendall (Director) | Option Ex | 4,166 | 5.46 | 22,746 |
| 2021-12-23 | Kaye Edward M. Md (Director) | Sale | 15,000 | 45.00 | 675,000 |
| 2021-12-23 | Kaye Edward M. Md (Director) | Option Ex | 15,000 | 7.61 | 114,150 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYTK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytokinetics Inc (symbol CYTK, CIK number 1061983) see the Securities and Exchange Commission (SEC) website.